PT1117390E - Sistemas de distribuicao de farmacos originarios da mucosa e aplicacoes em animais - Google Patents

Sistemas de distribuicao de farmacos originarios da mucosa e aplicacoes em animais

Info

Publication number
PT1117390E
PT1117390E PT99954718T PT99954718T PT1117390E PT 1117390 E PT1117390 E PT 1117390E PT 99954718 T PT99954718 T PT 99954718T PT 99954718 T PT99954718 T PT 99954718T PT 1117390 E PT1117390 E PT 1117390E
Authority
PT
Portugal
Prior art keywords
animals
pharmacies
mucosa
originating
applications
Prior art date
Application number
PT99954718T
Other languages
English (en)
Inventor
Charles J Matson
Chen Yen-Lane
Daniel T Ruth
Luce R M Benes
Sophie G Burgaud
Francoise L R Horriere
Isabelle M L Seyler
Original Assignee
3M Innovative Properties Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 3M Innovative Properties Co filed Critical 3M Innovative Properties Co
Publication of PT1117390E publication Critical patent/PT1117390E/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/38Drugs for disorders of the endocrine system of the suprarenal hormones
    • A61P5/46Drugs for disorders of the endocrine system of the suprarenal hormones for decreasing, blocking or antagonising the activity of glucocorticosteroids

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Endocrinology (AREA)
  • Biomedical Technology (AREA)
  • Diabetes (AREA)
  • Nutrition Science (AREA)
  • Rheumatology (AREA)
  • Anesthesiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Reproductive Health (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Physiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
PT99954718T 1998-10-02 1999-10-01 Sistemas de distribuicao de farmacos originarios da mucosa e aplicacoes em animais PT1117390E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US10295698P 1998-10-02 1998-10-02

Publications (1)

Publication Number Publication Date
PT1117390E true PT1117390E (pt) 2005-01-31

Family

ID=22292601

Family Applications (1)

Application Number Title Priority Date Filing Date
PT99954718T PT1117390E (pt) 1998-10-02 1999-10-01 Sistemas de distribuicao de farmacos originarios da mucosa e aplicacoes em animais

Country Status (19)

Country Link
EP (1) EP1117390B1 (pt)
JP (1) JP2002526403A (pt)
KR (1) KR20010075528A (pt)
CN (1) CN1321086A (pt)
AT (1) ATE273698T1 (pt)
AU (1) AU768040B2 (pt)
BR (1) BR9915020A (pt)
CA (1) CA2345808A1 (pt)
CZ (1) CZ20011188A3 (pt)
DE (1) DE69919554T2 (pt)
ES (1) ES2228125T3 (pt)
HU (1) HUP0103543A2 (pt)
IL (1) IL142168A0 (pt)
MX (1) MXPA01003310A (pt)
NO (1) NO20011656D0 (pt)
NZ (1) NZ510771A (pt)
PL (1) PL347061A1 (pt)
PT (1) PT1117390E (pt)
WO (1) WO2000019987A1 (pt)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6331539B1 (en) 1999-06-10 2001-12-18 3M Innovative Properties Company Sulfonamide and sulfamide substituted imidazoquinolines
DE10107659B4 (de) * 2001-02-19 2008-03-13 Lts Lohmann Therapie-Systeme Ag Mucoadhäsive zerfallsfähige Arzneizubereitung zur Wirkstoffverabreichung in der Veterinär- und Humanmedizin
EP1673087B1 (en) 2003-10-03 2015-05-13 3M Innovative Properties Company Alkoxy substituted imidazoquinolines
EP1687307B1 (en) 2003-11-25 2016-01-06 3M Innovative Properties Company Substituted imidazo ring systems and methods
FI20041425A0 (fi) * 2004-11-05 2004-11-05 Orion Corp Transmukosaalinen veterinäärinen koostumus
CA2597092A1 (en) 2005-02-04 2006-08-10 Coley Pharmaceutical Group, Inc. Aqueous gel formulations containing immune reponse modifiers
JP2006335640A (ja) * 2005-05-06 2006-12-14 Daicho Kikaku:Kk 動物用薬剤
KR101464003B1 (ko) * 2005-07-29 2014-11-20 산텐 세이야꾸 가부시키가이샤 고형 조성물을 이용한 후안부 조직으로의 비침습성 약물전달 시스템
JP2009528900A (ja) * 2006-03-07 2009-08-13 オラヘルス コーポレーション 不透過性中央部を有した医療用多層パッチ
KR101230804B1 (ko) * 2006-07-21 2013-02-08 바이오딜리버리 사이언시스 인터내셔널 인코포레이티드 향상된 흡수를 갖는 경점막 전달 장치
DE202008017304U1 (de) 2008-02-29 2009-08-27 Acino Ag Oral zerfallender Film zur therapeutischen Anwendung von Antiparasitika bei Tieren
RU2572692C2 (ru) * 2009-05-15 2016-01-20 Рекро Фарма, Инк. Сублингвальные композиции дексмедетомидина и способы их применения
BR112012000951A2 (pt) * 2009-07-17 2016-03-15 Univ Oklahoma State método para imunizar um animal, formulação imunogênica, e, aplicador supralingual
EP2570217B1 (de) 2011-09-15 2014-11-05 Klingelnberg AG Semi-Completing Wälzschälverfahren und Vorrichtung mit entsprechendem Wälzschälwerkzeug zum Ausführen eines Semi-Completing Wälzschälverfahrens
US9901539B2 (en) 2011-12-21 2018-02-27 Biodelivery Sciences International, Inc. Transmucosal drug delivery devices for use in chronic pain relief
ES2855103T3 (es) * 2013-10-07 2021-09-23 Teikoku Pharma Usa Inc Dispositivo de suministro transdérmico para el control del dolor que comprende composiciones transdérmicas de dexmedetomidina
CN105764494A (zh) 2013-10-07 2016-07-13 帝国制药美国公司 右旋美托咪啶经皮递送装置及其使用方法
JP6188933B2 (ja) 2013-10-07 2017-08-30 テイコク ファーマ ユーエスエー インコーポレーテッド 非鎮静量のデクスメデトミジンの経皮送達用方法及び組成物
RU2658463C2 (ru) 2013-10-07 2018-06-21 ТЕЙКОКУ ФАРМА ЮЭсЭй, ИНК. Способы и композиции для лечения синдрома дефицита внимания и гиперактивности, тревожности и бессонницы с применением трансдермальных композиций на основе дексмедетомидина
KR101881791B1 (ko) * 2013-10-07 2018-07-25 테이코쿠 팔마 유에스에이, 인코포레이티드 비진정성 덱스메데토미딘 경피 조성물을 사용하여 금단 증후군을 치료하기 위한 방법 및 조성물

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB981372A (en) * 1960-05-04 1965-01-27 Pfizer Ltd Pharmaceutical formulations for oral administration to animals
GB1455251A (en) * 1972-08-25 1976-11-10 Evode Ltd Method of sealing gaps and compositions therefor heat
US5656286A (en) * 1988-03-04 1997-08-12 Noven Pharmaceuticals, Inc. Solubility parameter based drug delivery system and method for altering drug saturation concentration
US5346701A (en) * 1993-02-22 1994-09-13 Theratech, Inc. Transmucosal delivery of macromolecular drugs
FR2712807B1 (fr) * 1993-11-24 1996-02-23 Vetoquinol Sa Composition solide mucoadhésive, thérapeutique ou hygiénique, pour administration par application sur la muqueuse buccale ou nasale .
US5688520A (en) * 1995-03-29 1997-11-18 Minnesota Mining And Manufacturing Company Transmucosal delivery of melatonin for prevention of migraine

Also Published As

Publication number Publication date
CA2345808A1 (en) 2000-04-13
PL347061A1 (en) 2002-03-11
JP2002526403A (ja) 2002-08-20
MXPA01003310A (es) 2003-05-15
NO20011656L (no) 2001-04-02
WO2000019987A1 (en) 2000-04-13
EP1117390B1 (en) 2004-08-18
KR20010075528A (ko) 2001-08-09
AU768040B2 (en) 2003-11-27
AU1100100A (en) 2000-04-26
IL142168A0 (en) 2002-03-10
ES2228125T3 (es) 2005-04-01
HUP0103543A2 (hu) 2002-01-28
NO20011656D0 (no) 2001-04-02
BR9915020A (pt) 2001-08-14
NZ510771A (en) 2003-08-29
EP1117390A1 (en) 2001-07-25
CN1321086A (zh) 2001-11-07
DE69919554T2 (de) 2005-09-01
ATE273698T1 (de) 2004-09-15
CZ20011188A3 (cs) 2001-08-15
DE69919554D1 (de) 2004-09-23

Similar Documents

Publication Publication Date Title
PT1117390E (pt) Sistemas de distribuicao de farmacos originarios da mucosa e aplicacoes em animais
ATE417604T1 (de) Matrix mit verzögerter freisetzung für hochdosierte unlösliche arzneistoffe
PT966447E (pt) Moleculas pequenas uteis no tratamento de doencas inflamatorias
ATE211907T1 (de) Osmotisches arzneimittelfreisetzungssystem
HUP0300246A2 (en) Delivery system
PT1019040E (pt) Inibicao da actividade de p38-quinase por meio de arilureias
BRPI0411924A (pt) métodos e dispositivos para oclusão de lúmens de corpo e/ou para fornecimento de agentes terapêuticos
CY1107628T1 (el) Ανθρωπινα ctla-4 αντισωματα και χρησεις αυτων
ES2091737T3 (es) Formulaciones farmaceuticas de fluoxetina.
DE59906392D1 (de) Hyaluronatlyase als penetrationsförderer in topischen mitteln
FR2819723B1 (fr) Composition halogene, son procede de preparation et ses utilisations
ATE337712T1 (de) Zusammensetzung zur intestinalen verabreichung
ATE226588T1 (de) Phosphinsäure-derivate
ATE249835T1 (de) Immunoregulator
ATE252910T1 (de) Methode zur behandlung von fruchtbarkeitsstörungen
PT1051187E (pt) Tratamento de linfomas foliculares usando inibidores da via da linfotoxina (lt)
TR200100637T2 (tr) Yeni doğal ürün türevleri
ATE290857T1 (de) Bretyliumhaltige zusammensetzungen und kits und deren verwendung zur vorbeugung und behandlung cardiovaskulärer erkrankungen
ATE261724T1 (de) Antikonvulsive derivate zur behandlung von posttraumatischen stresserkrankungen
MX9803610A (es) Utilizacion de flupirtina para la profilaxis y la terapia de enfermedades que van a compañadas de un deterioro del sistema celular hermatopoyetico.
NO20020914D0 (no) Alkoksy-substituerte benzimidazolforbindelser, preparater inneholdende slike samt anvendelser derav
UA31156A (uk) Спосіб лікування пневмоентеритів телят
FR2783396B1 (fr) Dispositif de diffusion lente de produits de traitement, notamment phytosanitaires
UA32111A (uk) Спосіб одержання препарату для лікування захворювань опорно-рухового апарату
ITMI981648A0 (it) Procedimento perfezionato per la produzione di combustibile da rifiuto e impianto per la realizzazione del detto procedimento